D. E. Shaw & Co., Inc. Zoetis Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $27,798 - $43,482	-300 Reduced 2.0%	14,700 $1.73 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $1.13 Million - $1.28 Million	10,000 Added 200.0%	15,000 $1.87 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $158,560 - $190,540	-2,000 Reduced 28.57%	5,000 $428,000
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $351,560 - $392,480	4,400 Added 169.23%	7,000 $596,000
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $185,926 - $220,194	2,600 New	2,600 $217,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.